Can prostate-specific antigen reverse transcriptase-polymerase chain reaction be used as a prospective test to diagnose prostate cancer?
Howard Brian Goldman, Ron Israeli, Yi Lu et al. · World Journal of Urology · 1997
Cited by 5 works. doi:10.1007/bf01367664
Authors
References
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
- Cancer statistics, 1996
- LNCaP model of human prostatic carcinoma.
- Correlation of pathologic findings with progression after radical retropubic prostatectomy
- PCR Technology: Principles and Applications for DNA Amplification
- Serial Prostatic Biopsies in Men with Persistently Elevated Serum Prostate Specific Antigen Values
- The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit.
- Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay
- Molecular cloning of human prostate specific antigen cDNA